StockData

Baird Medical Investment vs Retractable Technologies

BDMD and RVP side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BDMD and RVP compare

Retractable Technologies grew revenue faster over the last twelve months (−11.2% versus −39.2% for Baird Medical Investment).

Retractable Technologies keeps more of each dollar of sales as profit, with a net margin of −9.9% compared with −121% at Baird Medical Investment.

Retractable Technologies scores higher on the StockData Score (11 against 2 for Baird Medical Investment), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBDMDRVP
Size and price
Market cap–$16.8M
Share price$0.090$0.560
Change, 1 year−93.0%−32.9%
Change, 5 years–−93.6%
Beta (5Y)−0.050.79
Employees146201
StockData Score
Total score211 (better)
Valuation score03 (better)
Growth score01 (better)
Performance score03 (better)
Health score24 (better)
Dividend score00
Valuation
P/S–0.5×
P/B–0.2×
Fair value–$3.15
Margin of safety–82.2%
Growth
Revenue growth (TTM)−39.2%−11.2% (better)
Revenue growth, 5Y average–−14.1%
Net income growth (TTM)−319%–
EPS growth (TTM)−272%–
Profitability
Gross margin83.8% (better)−1.4%
Operating margin−114%−66.9% (better)
Net margin−121%−9.9% (better)
FCF margin−6.2%–
Return on equity−77.5%−4.5% (better)
Return on invested capital−48.2%−24.8% (better)
Financial health
Debt / equity0.22 (better)0.00
Interest coverage−72.3× (better)−278.8×
Current ratio1.294.93 (better)
Altman Z-score–0.42
Piotroski F-score15 (better)
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions–8.8%
Held by insiders62.0%55.7%
Insider net buying, 12 months–$0
Short interest, % of float–0.17%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.